•Expertos advierten que los cortes de USAID impiden el acceso a lenacapavir, un fármaco inyectable revolucionario para la prevención del VIH que podría reducir s...
•Injectable lenacapavir shows 99% effectiveness for HIV prevention globally, but USAID funding cuts threaten access to vulnerable populations worldwide.
•Injectable lenacapavir shows promise for HIV prevention worldwide, yet funding cuts limit access. Experts warn of setbacks in fighting the epidemic at Aids 2026...
•Lenacapavir injectable PrEP offers 99% HIV prevention effectiveness, but USAID funding cuts threaten global access. Experts warn of widening health disparities.
•Lenacapavir injectable PrEP shows promise for reducing HIV cases worldwide, but USAID funding cuts threaten access in vulnerable regions. Expert insights from A...
•Injectable lenacapavir shows promise for HIV prevention worldwide, but USAID funding cuts threaten access to vulnerable populations, experts warn.